IN2012DN05143A - - Google Patents
Download PDFInfo
- Publication number
- IN2012DN05143A IN2012DN05143A IN5143DEN2012A IN2012DN05143A IN 2012DN05143 A IN2012DN05143 A IN 2012DN05143A IN 5143DEN2012 A IN5143DEN2012 A IN 5143DEN2012A IN 2012DN05143 A IN2012DN05143 A IN 2012DN05143A
- Authority
- IN
- India
- Prior art keywords
- present
- glioma
- tbs40
- nfl
- peptide
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
- A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
- A61K49/0039—Coumarin dyes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
- A61K49/0056—Peptides, proteins, polyamino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56966—Animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57557—Immunoassay; Biospecific binding assay; Materials therefor for cancer of other specific parts of the body, e.g. brain
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cell Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Zoology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Marine Sciences & Fisheries (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US28620709P | 2009-12-14 | 2009-12-14 | |
| EP09306227A EP2332560A1 (en) | 2009-12-14 | 2009-12-14 | Use of a neurofilament peptide for the treatment of glioma |
| PCT/EP2010/069663 WO2011073207A1 (en) | 2009-12-14 | 2010-12-14 | Use of a neurofilament peptide for the treatment of glioma |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2012DN05143A true IN2012DN05143A (enExample) | 2015-10-23 |
Family
ID=42133636
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN5143DEN2012 IN2012DN05143A (enExample) | 2009-12-14 | 2010-12-14 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US9446092B2 (enExample) |
| EP (2) | EP2332560A1 (enExample) |
| JP (1) | JP5806679B2 (enExample) |
| CN (1) | CN102821777B (enExample) |
| CA (1) | CA2784091C (enExample) |
| IN (1) | IN2012DN05143A (enExample) |
| WO (1) | WO2011073207A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2869909B1 (fr) * | 2004-05-04 | 2007-12-21 | Univ Angers | Peptide capable d'inhiber la polymerisation de la tubuline et son utilisation pour inhiber la proliferation cellulaire |
| EP2959913A1 (en) * | 2014-06-23 | 2015-12-30 | Universite D'angers | Use of a neurofilament peptide for targeting neural stem cells |
| JP6612063B2 (ja) * | 2015-06-11 | 2019-11-27 | 国立大学法人滋賀医科大学 | 悪性神経膠腫分子標的ペプチド |
| US10550388B2 (en) * | 2017-08-15 | 2020-02-04 | The Board Of Trustees Of The Leland Stanford Junior University | Targeting pleiotrophin signaling to limit high-grade glioma invasion |
| CN108490191B (zh) * | 2018-03-13 | 2019-04-16 | 首都医科大学附属北京地坛医院 | 神经丝蛋白轻链在梅毒血液检测中的应用 |
| WO2020074691A1 (en) * | 2018-10-12 | 2020-04-16 | Advanced Accelerator Applications International Sa | Pharmaceutical composition comprising a radiolabeled gprp antagonist and a surfactant |
| CN112824427B (zh) * | 2019-11-18 | 2022-06-24 | 杨小骏 | 一种抑制胶质瘤的短肽及其应用 |
| EP4593865A1 (en) * | 2022-09-30 | 2025-08-06 | Gliocure | Pharmaceutical composition comprising nfl-tbs40-63peptide, variants or salts thereof and alanine |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2869909B1 (fr) | 2004-05-04 | 2007-12-21 | Univ Angers | Peptide capable d'inhiber la polymerisation de la tubuline et son utilisation pour inhiber la proliferation cellulaire |
-
2009
- 2009-12-14 EP EP09306227A patent/EP2332560A1/en not_active Withdrawn
-
2010
- 2010-12-14 IN IN5143DEN2012 patent/IN2012DN05143A/en unknown
- 2010-12-14 EP EP10787813.4A patent/EP2512499B1/en active Active
- 2010-12-14 CA CA2784091A patent/CA2784091C/en active Active
- 2010-12-14 US US13/514,884 patent/US9446092B2/en active Active
- 2010-12-14 JP JP2012543695A patent/JP5806679B2/ja active Active
- 2010-12-14 WO PCT/EP2010/069663 patent/WO2011073207A1/en not_active Ceased
- 2010-12-14 CN CN201080061959.6A patent/CN102821777B/zh active Active
-
2016
- 2016-08-05 US US15/229,534 patent/US20170000846A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| JP2013513646A (ja) | 2013-04-22 |
| US9446092B2 (en) | 2016-09-20 |
| CA2784091C (en) | 2020-08-11 |
| CN102821777B (zh) | 2014-12-17 |
| US20170000846A1 (en) | 2017-01-05 |
| EP2512499B1 (en) | 2015-09-16 |
| CN102821777A (zh) | 2012-12-12 |
| JP5806679B2 (ja) | 2015-11-10 |
| EP2332560A1 (en) | 2011-06-15 |
| CA2784091A1 (en) | 2011-06-23 |
| EP2512499A1 (en) | 2012-10-24 |
| US20130004429A1 (en) | 2013-01-03 |
| WO2011073207A1 (en) | 2011-06-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2012DN05143A (enExample) | ||
| SA515360657B1 (ar) | مثبطات ديميثيلاز هيستون | |
| NO20091661L (no) | Anvendelse av pegylert IL-10 for a behandle kreft | |
| MX2012003770A (es) | Metodos para la modulacion de autofagia a traves de la modulacion de productos de genes que aumentan la autofagia. | |
| EA201291107A1 (ru) | Соединения, ингибирующие металлоферменты | |
| MY184882A (en) | Indazole-3-carboxamides and their use as wnt/b-catenin signaling pathyway inhibitors | |
| WO2012034116A3 (en) | Small molecules as epigenetic modulators of lysine-specific demethylase 1 and methods of treating disorders | |
| MX2009008096A (es) | Moduladores de los componentes de enlace de esclerostatina para el tratamiento de trastornos relacionados con los huesos. | |
| NO20076401L (no) | Diarylhydantoinforbindelser | |
| MX2010002312A (es) | Compuestos de triazolopiridina y su uso como inhibidores de cinasa reguladora de señal de apoptosis. | |
| WO2010017515A3 (en) | Breast cancer specific markers and methods of use | |
| UA102250C2 (ru) | Двухзамещенные фталазины - антагонисты проводящего пути hedgehog | |
| WO2008005954A3 (en) | Tryphostin-analogs for the treatment of cell proliferative diseases | |
| EA200970403A1 (ru) | Бициклические триазолы в качестве модуляторов протеинкиназы | |
| TN2011000221A1 (en) | Pyrazine compounds as phosphodiesterase 10 inhibitors | |
| MX2009008461A (es) | Variantes geneticas que contribuyen a riesgo de cancer de prostata. | |
| EA200971068A1 (ru) | Триазолиламинопиримидиновые соединения | |
| MX2009011346A (es) | Tapentadol para tratamiento de dolor con artritis. | |
| MX349550B (es) | 1,7-diazacarbazoles y metodos de uso. | |
| TN2011000166A1 (en) | Disubstituted phthalazine hedgehog pathway antagonists | |
| MY150600A (en) | Use of opioid antagonists for treating urinary retention | |
| GEP20125647B (en) | Kinesin inhibitors as cancer therapeutics | |
| WO2008144507A3 (en) | Spirooxindole inhibitors of aurora kinase | |
| MX2010006039A (es) | Compuestos antagonistas del acido ribonucleico para la modulacion de la expresion de la fosfoinositida-3-cinasa catalitica. | |
| MX2007016469A (es) | Metodos de tratamiento utilizando ansamicinas de hidroquinona. |